PAVmed Acquires EsophaCap Manufacturer CapNostics LLC
October 07, 2021 11:41 ET
|
PAVmed Inc.
NEW YORK, Oct. 07, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
Tim Baxter, Former CEO of Samsung Electronics North America and Global Technology Industry Leader, Joins PAVmed Board of Directors
June 14, 2021 09:30 ET
|
PAVmed Inc.
NEW YORK, June 14, 2021 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multi-product, commercial-stage medical technology company, today...
Global Intraosseous Infusion Device Market – Increasing number of surgical procedures, increasing research & development, and adoption of expansion strategies aresome of the major factors driving market growth - by PMI
December 24, 2020 10:05 ET
|
PMI
Covina, CA, Dec. 24, 2020 (GLOBE NEWSWIRE) -- Greater focus on designing automated intraosseous infusion devices is expected to offer lucrative growth opportunities for players in the global...
PAVmed Adds EsoCure™ Esophageal Ablation Device with Patented Caldus™ Technology to Commercial Product Pipeline
February 18, 2020 09:30 ET
|
PAVmed Inc.
Disposable single-use device designed to provide safer, more efficient and cost-effective ablation of dysplastic Barrett’s Esophagus, complementing Lucid Diagnostics’ EsoGuard™ and EsoCheck™ products ...
PAVmed to Hold Business Update Conference Call on May 21, 2019
May 06, 2019 09:30 ET
|
PAVmed Inc.
NEW YORK, May 06, 2019 (GLOBE NEWSWIRE) -- PAVmed Inc. (Nasdaq: PAVM, PAVMZ) (the “Company” or “PAVmed”), a highly differentiated, multiproduct medical device company, today announced that the...